Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic salt-inducible kinase inhibitors

Macrocyclic salt-inducible kinase inhibitors

US Patent 9586975 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiolabeled macrocyclic EGFR inhibitor2020
Radiolabeled macrocyclic EGFR inhibitor2020
Macrocyclic RIP2 kinase inhibitors2020
Carbazole and carboline compounds for use in the diagnosis, treatment, alleviati2020
Compounds for the treatment of diseases associated with amyloid or amyloid-like 2019
Macrocyclic LRRK2 kinase inhibitors2019
Macrocyclic LRRK2 kinase inhibitors2019
Macrocyclic FLT3 kinase inhibitors2016
Macrocyclic FLT3 kinase inhibitors2016
Macrocyclic LRRK2 kinase inhibitors2016
Macrocyclic LRRK2 kinase inhibitors2016
Compounds for the treatment of diseases associated with amyloid or amyloid-like 2015